JP2016519143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519143A5 JP2016519143A5 JP2016513900A JP2016513900A JP2016519143A5 JP 2016519143 A5 JP2016519143 A5 JP 2016519143A5 JP 2016513900 A JP2016513900 A JP 2016513900A JP 2016513900 A JP2016513900 A JP 2016513900A JP 2016519143 A5 JP2016519143 A5 JP 2016519143A5
- Authority
- JP
- Japan
- Prior art keywords
- dextran sulfate
- subject
- pharmaceutically acceptable
- waso
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000633 dextran sulfate Drugs 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 239000000203 mixture Substances 0.000 claims 6
- 210000000130 stem cell Anatomy 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 230000006041 cell recruitment Effects 0.000 claims 4
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 3
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 3
- 210000005259 peripheral blood Anatomy 0.000 claims 3
- 239000011886 peripheral blood Substances 0.000 claims 3
- 230000007115 recruitment Effects 0.000 claims 3
- 230000017531 blood circulation Effects 0.000 claims 2
- 210000000265 leukocyte Anatomy 0.000 claims 2
- 210000004698 lymphocyte Anatomy 0.000 claims 2
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 210000002960 bfu-e Anatomy 0.000 claims 1
- 230000001332 colony forming effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 229940102223 injectable solution Drugs 0.000 claims 1
- 210000003593 megakaryocyte Anatomy 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 claims 1
- 210000003924 normoblast Anatomy 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1350584A SE537742C2 (sv) | 2013-05-13 | 2013-05-13 | Dextransulfat för cellmobilisering |
| SE1350584-7 | 2013-05-13 | ||
| PCT/SE2014/050576 WO2014185851A1 (en) | 2013-05-13 | 2014-05-12 | Dextran sulfate for use in mobilization of cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519143A JP2016519143A (ja) | 2016-06-30 |
| JP2016519143A5 true JP2016519143A5 (enExample) | 2017-06-22 |
| JP6339668B2 JP6339668B2 (ja) | 2018-06-06 |
Family
ID=51898693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513900A Active JP6339668B2 (ja) | 2013-05-13 | 2014-05-12 | 細胞動員に使用するデキストラン硫酸 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10258642B2 (enExample) |
| EP (1) | EP2999478B1 (enExample) |
| JP (1) | JP6339668B2 (enExample) |
| CN (1) | CN105358159B (enExample) |
| CA (1) | CA2912366C (enExample) |
| DK (1) | DK2999478T3 (enExample) |
| ES (1) | ES2780907T3 (enExample) |
| PL (1) | PL2999478T3 (enExample) |
| SE (1) | SE537742C2 (enExample) |
| WO (1) | WO2014185851A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10407514B2 (en) | 2014-11-11 | 2019-09-10 | Tx Medic Ab | Dextran sulfate |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
| RU2623152C9 (ru) * | 2015-10-15 | 2022-02-17 | Акционерное общество "Федеральный научно-производственный центр "Алтай" | Композиция, обладающая гепатопротекторными и иммуностимулирующими свойствами |
| CN114127262A (zh) * | 2019-05-16 | 2022-03-01 | 香港中文大学 | 细胞外基质材料及其用途 |
| SE544015C2 (en) * | 2019-06-18 | 2021-11-02 | Tx Medic Ab | Allogenic car-t cell therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454560A (en) | 1966-03-01 | 1969-07-08 | Seikagaku Kogyo Co Ltd | Process for the production of chondroitin polysulfate |
| SE525461C3 (sv) | 2002-11-28 | 2005-03-23 | Prophymed Ab | Ny användning av dextransulfat |
| CN1589904A (zh) | 2003-09-01 | 2005-03-09 | 北京大学 | 造血干细胞动员剂制备治疗糖尿病药物的用途 |
-
2013
- 2013-05-13 SE SE1350584A patent/SE537742C2/sv unknown
-
2014
- 2014-05-12 EP EP14797927.2A patent/EP2999478B1/en active Active
- 2014-05-12 ES ES14797927T patent/ES2780907T3/es active Active
- 2014-05-12 DK DK14797927.2T patent/DK2999478T3/da active
- 2014-05-12 WO PCT/SE2014/050576 patent/WO2014185851A1/en not_active Ceased
- 2014-05-12 CN CN201480038833.5A patent/CN105358159B/zh active Active
- 2014-05-12 JP JP2016513900A patent/JP6339668B2/ja active Active
- 2014-05-12 CA CA2912366A patent/CA2912366C/en active Active
- 2014-05-12 US US14/890,636 patent/US10258642B2/en active Active
- 2014-05-12 PL PL14797927T patent/PL2999478T3/pl unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10407514B2 (en) | 2014-11-11 | 2019-09-10 | Tx Medic Ab | Dextran sulfate |
| US10730960B2 (en) | 2014-11-11 | 2020-08-04 | Tx Medic Ab | Dextran sulfate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016519143A5 (enExample) | ||
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| MX2017004592A (es) | Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos. | |
| JP2013147511A5 (enExample) | ||
| HRP20211442T1 (hr) | Kombinacija za liječenje parkinsonove bolesti | |
| JP2016539921A5 (enExample) | ||
| EP4606430A3 (en) | Use of il-22 dimer in manufacture of a medicament for intravenous administration | |
| Elliott et al. | The safety and effect of multiple doses of vorinostat on HIV transcription in HIV-infected patients receiving combination antiretroviral therapy | |
| HRP20210010T1 (hr) | Injekcijske farmaceutske formulacije lefamulina | |
| WO2016040814A3 (en) | Disulfide polymers and methods of use | |
| JP2012217972A5 (enExample) | ||
| HRP20201696T1 (hr) | Farmaceutska parenteralna formulacija koja sadrži kargluminsku kiselinu | |
| HRP20241042T1 (hr) | Novi analozi inzulina i njihova upotreba | |
| BR112015022084A2 (pt) | composições para uso em tratamento de distúrbios oculares com o uso de dipiridamol | |
| FI3144002T3 (fi) | Granulosyytti-makrofagikasvutekijää (GM-CSF) tuottava T-solusäätelyaine sekä Th1/Th2-immuunitasapainon säätelijä | |
| JP2014533256A5 (enExample) | ||
| JP2017531042A5 (enExample) | ||
| JP2010538054A5 (enExample) | ||
| JP2016528283A5 (enExample) | ||
| MX2017004633A (es) | Formulaciones que contienen tiotropio, aminoacidos y acidos, y metodos de estas. | |
| CN104000809B (zh) | 一种防治冠心病心绞痛的药物组合物及其应用 | |
| JP2017517574A5 (enExample) | ||
| JP2017508455A5 (enExample) | ||
| CN203280640U (zh) | 一种床头尾板 | |
| EP2606885A4 (en) | "RENESSANS" MEDICINAL PREPARATION WITH ANTIBACTERIAL, ANTI-ULCER AND IMMUNOMODULATORY ACTION |